Generation of Anti-c-Met Single Domain Antibody Fragment Based on Human Stable Frameworks

被引:0
作者
Edwardraja, Selvakumar [1 ,2 ]
Sokalingam, Sriram [1 ]
Raghunathan, Govindan [1 ]
Hwang, Bum-Yeol [3 ]
Lee, Sun-Gu [1 ]
机构
[1] Pusan Natl Univ, Dept Chem Engn, Pusan 609735, South Korea
[2] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA
[3] Univ Calif Berkeley, Dept Chem & Biomol Engn, Inst QB3, Berkeley, CA 94720 USA
关键词
antibody engineering; single domain antibody; CDR grafting; human stable framework; CHAIN FV ANTIBODY; ESCHERICHIA-COLI; VARIABLE DOMAINS; PROTEINS; STABILITY; THERAPY; SOLUBILITY; EXPRESSION; VH;
D O I
10.1007/s12257-012-0378-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The size reduction is an important issue in the biomedical application of antibody and single domain antibody fragment is recognized as very attractive tool. However, it is very time-consuming and laborious to generate the fragment antibody with targeted binding function. Here, we investigated the possibility to prepare single domain antibody (sdAb) by a simple grafting method based on stable human consensus framework sequences. The complementarity determining region sequences in V-H domain of anti-c-Met scFv from rabbit were grafted with the human V(H)3 consensus framework sequences, which generated the anti-c-Met single domain antibody showing almost same binding activity to its scFv form. The generated single domain antibody could be produced as functional form in oxidizing cytoplasm of E. coli, but produced as inactive form in reducing cytoplasm. The structural analysis of the homology models gave us the insight on the stability of the single domain antibody. In this report, we have demonstrated that the very stable human consensus framework sequence can be used for the generation of active anti-c-Met sdAb via complementarity determining regions grafting. We expect that this kind of grafting method for the generation of sdAb may provide us with the opportunities to prepare sdAbs based on the known antibody sequences.
引用
收藏
页码:1120 / 1127
页数:8
相关论文
共 24 条
  • [11] Functional expression of single-chain variable fragment antibody against c-Met in the cytoplasm of Escherichia coli
    Heo, Mi-Ae
    Kim, Su-Hyun
    Kim, So-Yeon
    Kim, Yu-Jin
    Chung, Junho
    Oh, Mm-Kyu
    Lee, Sun-Gu
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2006, 47 (01) : 203 - 209
  • [12] Domain antibodies: proteins for therapy
    Holt, LJ
    Herring, C
    Jespers, LS
    Woolven, BP
    Tomlinson, IM
    [J]. TRENDS IN BIOTECHNOLOGY, 2003, 21 (11) : 484 - 490
  • [13] Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays
    Huang, L
    Reekmans, G
    Saerens, D
    Friedt, JM
    Frederix, F
    Francis, L
    Muyldermans, S
    Campitelli, A
    Van Hoof, C
    [J]. BIOSENSORS & BIOELECTRONICS, 2005, 21 (03) : 483 - 490
  • [14] Kim YJ, 2008, J MICROBIOL BIOTECHN, V18, P1186
  • [15] Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework
    Kuegler, Markus
    Stein, Christoph
    Schwenkert, Michael
    Saul, Domenica
    Vockentanz, Lena
    Huber, Thomas
    Wetzel, Svava K.
    Scholz, Oliver
    Plueckthun, Andreas
    Honegger, Annemarie
    Fey, Georg H.
    [J]. PROTEIN ENGINEERING DESIGN & SELECTION, 2009, 22 (03) : 135 - 147
  • [16] Salt bridge stability in monomeric proteins
    Kumar, S
    Nussinov, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (05) : 1241 - 1255
  • [17] Fabrication of Protein Microarrays Using the Electrospray Deposition (ESD) Method: Application of Microfluidic Chips in Immunoassay
    Lee, Bumhwan
    Tajima, Akihiko
    Kim, Joonwan
    Yamagata, Yutaka
    Nagamune, Teruyuki
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2010, 15 (01) : 145 - 151
  • [18] Production of cytidine 5′-monophosphate N-acetylneuraminic acid using recombinant Escherichia coli as a biocatalyst
    Lee, SG
    Lee, JO
    Yi, JK
    Kim, BG
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2002, 80 (05) : 516 - 524
  • [19] Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
    Lofblom, J.
    Feldwisch, J.
    Tolmachev, V.
    Carlsson, J.
    Stahl, S.
    Frejd, F. Y.
    [J]. FEBS LETTERS, 2010, 584 (12) : 2670 - 2680
  • [20] Disrupting the hydrophobic patches at the antibody variable/constant domain interface: Improved in vivo folding and physical characterization of an engineered scFv fragment
    Nieba, L
    Honegger, A
    Krebber, C
    Pluckthun, A
    [J]. PROTEIN ENGINEERING, 1997, 10 (04): : 435 - 444